Pre-congress virtual satellite symposium
Unlocking the potential: IL-23 pathway in immune-mediated diseases Wednesday, 18th May, 18:00-19:00 EDT
Simultaneous translation to Spanish and Portuguese will be available
After attending this event, participants should be able to:
◉ Examine the role of the interleukin (IL)-23 pathway in the pathophysiological mechanisms driving immune-mediated disease progression
◉ Describe the efficacy and safety data on targeting the IL-23 pathway in psoriatic arthritis (PsA), psoriasis (PsO), and inflammatory bowel disease (IBD), and consider how these data impact clinical practice
◉ 19:00 – Closing remarks. Kilian Eyerich
*This session is for healthcare professionals only.